Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches Josuel Ora, Dennis Jensen and Denis E.
|
|
- Christiana Anthony
- 5 years ago
- Views:
Transcription
1 Exertional dyspnea in chronic obstructive pulmonary disease: mechanisms and treatment approaches Josuel Ora, Dennis Jensen and Denis E. O Donnell Respiratory Investigation Unit, Department of Medicine, Queen s University and Kingston General Hospital, Kingston, Ontario, Canada Correspondence to Denis E. O Donnell, MD, FRCP(I), FRCP(C), Departments of Medicine & Physiology, Division of Respiratory & Critical Care Medicine, Queen s University and Kingston General Hospital, 102 Stuart Street, Kingston, ON K7L 2V6, Canada odonnell@queensu.ca Current Opinion in Pulmonary Medicine 2010, 16: Purpose of review The purpose of this review is to identify new advances in our understanding of dyspnea in patients with chronic obstructive pulmonary disease (COPD). Specifically, we highlight new scientific discoveries concerning the language of dyspnea, its underlying mechanisms and its clinical management. Recent findings Recent studies have confirmed that dyspnea is multidimensional and that sensory intensity and quality dimensions of the symptom are readily distinguishable by the individual. When respiratory discomfort is sufficiently unpleasant in COPD, an emotive response is evoked which encompasses feelings of fear and anxiety. Such descriptors appear to be unique to the disease state and are rarely reported in health. Recent brain imaging studies have proposed a central role of the limbic and paralimbic systems in the genesis of perceived dyspnea or its affective component. There is new indirect evidence that the elaboration of endogenous opioids may modulate dyspnea intensity during exercise in COPD. New physiological studies in COPD have provided novel insights into mechanisms of dyspnea both in early disease and in the setting of coexistent obesity. Summary The effective management of dyspnea in COPD remains a significant challenge for caregivers but recent treatment innovations such as helium oxygen, inhaled furosemide and breathing feedback techniques have yielded early positive results. Keywords bronchodilators, chronic obstructive pulmonary disease, dyspnea, exercise, heliox, inhaled furosemide Curr Opin Pulm Med 16: ß 2010 Wolters Kluwer Health Lippincott Williams & Wilkins Introduction Perceived respiratory difficulty (dyspnea) is the primary symptom limiting exercise in the majority of patients with chronic obstructive pulmonary disease (COPD) [1 ]. Persistent activity-related dyspnea often forces patients to adopt a sedentary lifestyle. Inactivity, in turn, inevitably leads to generalized skeletal muscle deconditioning, which further erodes perceived quality of life. Severe activity-related dyspnea is, therefore, a major contributor to morbidity in COPD and is an independent predictor of poor survival [2]. This brief review will focus on the latest publications on this topic and will concentrate on three different aspects: the language of dyspnea, new insights into the nature and mechanisms of exertional dyspnea in COPD, and novel therapeutic approaches. Language of dyspnea The idea that dyspnea is a simple unidimensional respiratory sensation has been abandoned in favor of a more complex construct which purports that dyspnea is multidimensional, and incorporates distinct sensory (intensity, quality) and affective (unpleasantness, fear, anxiety) components [3]. It is suggested that dyspnea encompasses distinct qualitative sensations that may have different underlying neurophysiological mechanisms. Major qualitative descriptors include: air hunger, sense of effort, unsatisfied inspiration, and chest tightness [4 6]. At the termination of cycle exercise when dyspnea intensity is severe, patients with moderate-tosevere COPD predominantly select qualitative descriptors that allude to the sense of unsatisfied inspiration (e.g. cannot get enough air in ) and increased effort/work ( my breathing requires more work or effort ). Unsatisfied inspiration is usually perceived as unpleasant and is more likely to evoke an emotive response than increased effort per se. Interestingly, healthy age-matched individuals select similar effort/work descriptors to those of COPD patients but rarely select descriptors in the unsatisfied inspiration cluster. This confirms that the experience of perceived breathing difficulty at the limits of ß 2010 Wolters Kluwer Health Lippincott Williams & Wilkins DOI: /MCP.0b013e328334a728
2 2 Obstructive, occupational and environmental diseases exercise tolerance is distinctly different in health and disease [7]. Qualitative descriptors of dyspnea in chronic obstructive pulmonary disease The pathophysiology of COPD and its sensory consequences are best considered in the context of the aging respiratory system, as most patients with the disease are elderly [8,9]. Williams et al. [10 ] recently addressed the important question of whether the language used to describe dyspnea could also be used to accurately categorize older individuals into those who have a diagnosis of COPD versus those who do not. They found that only patients with COPD volunteered words with affective connotations such as frightening and worried to describe their breathing difficulty. They also found that 85% of individuals could be correctly categorized within their original group (COPD or non-copd) using these descriptors of perceived respiratory difficulty. This work bolsters the argument that self-reported descriptions of dyspnea that encompass its emotive dimension (e.g. fear or anxiety) are more likely to have pathophysiological origins. This paper also highlights the importance of using greater precision in the language of dyspnea both for the purpose of clinical assessment and in the research setting. The affective dimension of perceived dyspnea A recent study by Banzett et al. [11 ] tested the validity of the multidimensional model of dyspnea. These investigators tested the hypothesis that different types of laboratory-induced dyspnea are capable of evoking different affective responses. In this study of 12 healthy individuals, the sense of air hunger (induced by constraining ventilation in the setting of hypercapnia) provoked a consistently greater affective response (i.e. more unpleasantness) than the sense of increased respiratory work/effort (induced by maximal eucapnic voluntary hyperpnea against inspiratory resistance) even though the intensity of these sensations were graded to be of similar magnitude by the participants. Brain imaging Von Leupoldt et al. [12 ] recently demonstrated that the perception of laboratory-induced dyspnea and pain are processed in common areas of the brain, including the anterior/mid insula, anterior cingulated cortex, amygdala and medial thalamus. These phylogenetically ancient areas of the brain are involved in the processing of emotions such as fear and anxiety (i.e. affective responses). They are known to become activated when threatening sensations such as dyspnea and pain are perceived, and likely represent a motivational drive originating in central limbic structures that initiates fight-or-flight behaviors to avoid the potential risk of suffocation or severe tissue damage. Recent advances in our understanding of dyspnea that have emerged from studies of brain imaging have been comprehensively reviewed by Davenport and Vovk [13]. Together, the studies of Williams, Banzett and Von Leupoldt highlight the importance of the much neglected affective component of dyspnea. There is now increasing support for the hypothesis that activation of central limbic structures contributes importantly to the conscious experience of perceived respiratory difficulty during physiological stress in humans. The corollary is that similar neural mechanisms are at play in the COPD patient during exercise when the perceived respiratory discomfort is sufficient to evoke an emotive response. The role of endogenous opioids It has long been proposed that the elaboration of endogenous opioids during physiological stress may modulate dyspnea or its affective dimension in COPD [14]. A recent randomized, double-blind, placebo-controlled, crossover study in 17 patients with moderate-to-severe COPD showed that the administration of naloxone, an opioid antagonist, consistently increased (vs. placebo) dyspnea intensity ratings during high-intensity constant-work-rate treadmill exercise [15 ]. There were no significant differences in physiological responses to exercise between treatments. Therefore, the increased dyspnea during naloxone was not related to any concomitant increase in central respiratory drive (or ventilation) due to reversal of endogenous opiate effects on ventilatory control. The differential impact of naloxone on the intensity, unpleasantness and affective domains of dyspnea in COPD remains to be determined. Collectively, these recent studies are sure to reignite interest in the study of the affective component of dyspnea in COPD. Further systematic study of interventions that ameliorate dyspnea by selectively targeting the central nervous system (e.g. behavioral modification, opioids, anxiolytics, etc.) are urgently needed. Exertional dyspnea in chronic obstructive pulmonary disease The study of the origins of exertional dyspnea in COPD has been hampered by the inability to precisely quantify central neural respiratory motor drive and/or sensory information from peripheral afferents in the lungs, airways, respiratory muscles and chemoreceptors. Moreover, the remarkable redundancy inherent in all somatosensory systems confounds interpretation of the results of traditional psychophysical experiments that utilize chemical and mechanical loading of the respiratory system to mimic the effects of disease. Current constructs of exertional dyspnea in COPD that emphasize the central role of increased contractile respiratory muscle effort and neuromechanical uncoupling of the respiratory system have been reviewed elsewhere and are summarized in Fig. 1 [9,16].
3 Dyspnea in chronic obstructive pulmonary disease Ora et al. 3 Figure 1 Proposed neurophysiological model of perceived respiratory discomfort (dyspnea) during exercise Briefly, the somatosensory cortex calibrates and interprets the appropriateness of the mechanical/muscular response of the respiratory system to the prevailing level of central respiratory motor drive. When the mechanical/muscular response of the respiratory system is constrained, by disease, below the level dictated or preprogrammed by central respiratory motor drive then the intensity of unsatisfied inspiration increases in direct proportion to the widening disparity between drive and mechanics (i.e. neuromechanical uncoupling). Increased activation of central limbic structures as a result of neuromechanical uncoupling is also a likely component of respiratory distress. V O 2 and V CO 2, metabolic rate of oxygen consumption and carbon dioxide production; Type III and IV mechanosensitive and metabosensitive afferents in the peripheral locomotor (and respiratory) muscles and their vasculature; PSRs, pulmonary stretch receptors; C-fibers, bronchopulmonary C-fibers; J-receptors, juxtapulmonary capillary receptors; GTOs, Golgi tendon organs; pco 2, partial pressure of carbon dioxide; [H þ ], hydrogen ion concentration; [La ], lactate ion concentration; pao 2, arterial partial pressure of oxygen; SaO 2, arterial blood oxygen saturation. Adapted with permission from [16].
4 4 Obstructive, occupational and environmental diseases Exertional dyspnea in mild chronic obstructive pulmonary disease Previous studies in more advanced COPD have shown that dyspnea is consistently associated with increased central respiratory drive and increased ventilatory stimulation. This in turn reflects increased chemostimulation secondary to the effects of disruption in ventilation/ perfusion relationships and pulmonary gas exchange. Mechanical constraints on tidal volume expansion as a result of dynamic pulmonary hyperinflation also undoubtedly contribute. Ofir et al. [17 ] were the first to study mechanisms of activity-related dyspnea in symptomatic patients with mild COPD (FEV 1 post bronchodilator at least 80%predicted and FEV 1 /FVC <0.7). These authors found that exercise capacity was significantly reduced and exertional dyspnea intensity was higher at a given work rate in the mild symptomatic COPD compared with age-matched healthy individuals. Despite the largely preserved FEV 1, the mild COPD group had higher ventilatory requirements for a given metabolic load throughout exercise, likely as a result of nonuniformity in ventilation/perfusion relations. Indeed the existence of such disruptions in pulmonary gas exchange in early COPD has recently been confirmed by Rodriguez- Roisin et al. [18 ]. In addition, these patients with mild airway obstruction (by FEV 1 criteria) had evidence of extensive small airway dysfunction. During exercise they showed significant dynamic pulmonary hyperinflation (with average increase in end-expiratory lung volume of 0.54 l) and a relatively rapid and shallow breathing pattern. Such dynamic hyperinflation is associated with increased elastic and inspiratory threshold loading of the inspiratory muscles and disrupts the normally harmonious relationship between increasing contractile respiratory muscle effort and simultaneous thoracic volume displacement during exercise, that is, neuromechanical coupling. To test the hypothesis that lung hyperinflation contributes to dyspnea even in mild COPD, the current authors examined the effect of acute administration of an inhaled anticholinergic bronchodilator [19 ]. Bronchodilator therapy (compared with placebo) was associated with consistent reduction of pulmonary resistance, dynamic hyperinflation and work of breathing during exercise. These mechanical improvements were linked to significant reduction in dyspnea intensity ratings at standardized ventilation during exercise. These studies have uncovered significant abnormalities in airway function in symptomatic patients with relative minor spirometric abnormalities and provide a solid physiological rationale for bronchodilator treatment in selected individuals. However, a limitation of these studies was that they were conducted in symptomatic patients; further studies are required to determine if these results can be extrapolated to patients with mild COPD who do not report troublesome dyspnea during daily activity. Dynamic lung hyperinflation during daily activities in chronic obstructive pulmonary disease Several studies have confirmed the importance of lung hyperinflation as a limiting factor for exercise performance and as a contributor to dyspnea in patients with COPD; however, there are no data about its impact on daily activities. In a study by Garcia-Rio et al. [20 ], 110 moderate-to-severe COPD patients performed a 6-min walk test, an incremental and a constant work-rate cycle exercise test and daily physical activity assessment measured by accelerometer. By multivariate linear regression, the extent of dynamic hyperinflation during the incremental exercise test (change in end-expiratory lung volume) and the 6-min walking distance were the best independent predictors of daily activity. Impact of obesity on exertional dyspnea in chronic obstructive pulmonary disease The prevalence of obesity and COPD is increasing dramatically throughout the Western World. Although both conditions have been studied in isolation, little is known about their interaction with respect to effects on dynamic respiratory mechanics and dyspnea. Ora et al. [21 ] recently studied 18 obese COPD and 18 normalweight COPD patients, well matched for age and FEV 1 (50% predicted), at rest and during incremental cycle exercise. Contrary to current assumptions regarding the deleterious effects of combining these two disorders, the investigators found that obese patients with COPD did not experience greater dyspnea or exercise limitation than normal-weight patients with comparable FEV 1. They argued that the negative consequences of obesity (i.e. increased metabolic load, increased ventilatory requirements and increased oxygen cost of breathing) were partly counterbalanced by the advantages (with respect to respiratory muscle performance) of breathing at a lower absolute lung volume. A similar conclusion was reached in a previous study, which examined the effects of obesity on exercise performance and respiratory sensation in individuals without airway obstruction [17 ]. Therapeutic approaches The effective management of dyspnea in COPD remains a significant challenge for caregivers but recent treatment innovations such as helium oxygen, inhaled furosemide and breathing feedback techniques have yielded early positive results. A new application for an old drug Several published studies have found that single-dose inhalation of furosemide, a powerful loop diuretic, appears
5 Dyspnea in chronic obstructive pulmonary disease Ora et al. 5 to modulate the activity of sensory afferents in the lungs and airways of laboratory animals. Inhaled furosemide was also shown to decrease the intensity of dyspnea provoked experimentally in healthy humans at rest [22]. Ong et al. [23] were the first to provide evidence that such treatment may have a possible clinical application in COPD. Jensen et al. [24 ] conducted a randomized, double-blind, placebocontrolled, crossover study to explore possible mechanisms of action of this drug in 20 patients with moderate-tosevere COPD. Nebulized furosemide treatment was associated with modest but consistent improvements in exercise endurance time and dyspnea; however, the magnitude of effect varied across patients. In that study, inhaled furosemide was associated with improvements in airway function with concomitant increases in dynamic inspiratory capacity, tidal volume and mean tidal expiratory flow rates. The mechanisms of improved airway function remain conjectural (e.g. reduced airway mucosal edema or modulation of vagal reflexes). Nevertheless, these preliminary studies on the effects of furosemide in both health and COPD collectively confirm that this drug has potential dyspnea-relieving properties (at least in selected individuals) that deserve further exploration. Adjuncts to pulmonary rehabilitation in chronic obstructive pulmonary disease Pulmonary rehabilitation is one of the most powerful interventions [25] at our disposal to improve activity-related dyspnea and quality of life in COPD. The mechanisms of improvement are complex but include both psychological (improved self-efficacy) and physiological (reduced ventilatoryrequirements) factors. A majorchallengehasbeenthe provision of an adequate training stimulus to achieve consistent physiological improvements in patients with severe ventilatory limitation and incapacitating dyspnea. This problem has prompted the development of a number of experimental strategies aimed at unloading the respiratory muscles and improving dynamic mechanics during exercise training (e.g. oxygen, heliox, bronchodilators, noninvasive mechanical ventilation) [26 31]. Eves et al. [32 ] recently demonstrated that breathing a mixture of helium hyperoxia (60% 40%)(helium hyperoxia) was superior to breathing room air in increasing the intensity and duration of the exercise-training stimulus in normoxic COPD patientsduringa 6-week rehabilitationprogram. Thisresult supports the hypothesis that the higher training intensity achievedduringmultimodality exercisetraining thegreater the clinical benefit. It remains to be determined whether adjunctive helium oxygen combinations are superior to more traditional approaches, which combine maximal bronchodilation with oxygensupplementation during exercise training. Biofeedback techniques Ventilation feedback training is another interesting technique that has been employed to improve the impact of pulmonary rehabilitation in COPD. The rationale here is to modify the respiratory pattern during exercise and specifically to reduce the respiratory rate (by increasing expiratory time) so as to facilitate lung deflation and reduce dynamic hyperinflation. In the study of Collins et al. [33 ], 64 moderate-to-severe COPD patients were divided into three groups and randomized to three interventions: ventilation feedback plus exercise, ventilation feedback alone and exercise alone. After 6 weeks of training, they found that ventilation feedback alone or in combination with exercise training modified breathing pattern (slower inspiratory and expiratory times with decrease in ventilation). Only ventilation feedback plus exercise training successfully reduced dynamic hyperinflation and dyspnea intensity ratings, compared with the other two interventions. However, the incorporation of breathing pattern biofeedback into the exercise-training regimen was not shown to have superior effects on cycle exercise endurance compared with unassisted training. Regardless, this study was the first to show that biofeedback methods can be successfully employed to improve dynamic respiratory mechanics and perceived respiratory discomfort during activity in COPD. Conclusion For patients with COPD, the effective amelioration of dyspnea remains an elusive goal. However, our understanding of the nature and source of this troublesome symptom continues to grow. Recent studies have elucidated the multidimensional nature of dyspnea and have shown that individuals can reliably discriminate between the intensity, quality and affective domains of this symptom. The affective dimension may be the dominant contributor to respiratory distress in mechanically compromised patients with COPD and may have its neurological origin in over-activation of the limbic and paralimbic systems of the brain. The ability to evaluate the impact of therapeutic interventions on dyspnea, in terms of its quality and affective response, opens up exciting new opportunities to advance this field of study. The stage is now set to more systematically test new therapeutic approaches that target the central nervous system and that modify the emotive response to perceived respiratory discomfort. Preliminary studies on the effect of innovative interventions such as helium oxygen inhaled furosemide and computerized ventilation biofeedback techniques all show promise and deserve further scrutiny. Acknowledgements Conflict of Interest Statement: Josuel Ora does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. Dennis Jensen does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. Dennis O Donnell has served on advisory boards for Boehringer Ingelheim, Pfizer, GSK, and Roche ($ ), has received lecture fees from Boehringer Ingelheim, Pfizer, and GSK
6 6 Obstructive, occupational and environmental diseases ($ ), and has received industry-sponsored grants from Boehringer Ingelheim, GSK, and Merck Frost Canada ($ or more) and from Novartis and Pfizer ($ ). References and recommended reading Papers of particular interest, published within the annual period of review, have been highlighted as: of special interest of outstanding interest Additional references related to this topic can also be found in the Current World Literature section in this issue (pp ). 1 O Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009; 34: This is the first large study to demonstrate that the measurement of endurance time operating lung volumes, ventilation, and ratings of dyspnea intensity is highly reproducible in COPD during high intensity, constant work rate cycle exercise. 2 Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002; 121: O Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4: Mahler DA, Baird JC. Are you fluent in the language of dyspnea? Chest 2008; 134: Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996; 154: Harver A, Mahler DA, Schwartzstein RM, Baird JC. Descriptors of breathlessness in healthy individuals: distinct and separable constructs. Chest 2000; 118: O Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155: Ofir D, Laveneziana P, Webb KA, et al. Sex differences in the perceived intensity of breathlessness during exercise with advancing age. J Appl Physiol 2008; 104: Jensen D, Ofir D, O Donnell DE. Effects of pregnancy, obesity and aging on the intensity of perceived breathlessness during exercise in healthy humans. Respir Physiol Neurobiol 2009; 167: Williams M, Cafarella P, Olds T, et al. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest 2008; 134: This paper highlights the importance of using greater precision in the language of dyspnea both for the purpose of clinical assessment and in the research setting. 11 Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/ effort. Am J Respir Crit Care Med 2008; 177: It is the first study to show that laboratory-induced air hunger was associated with an affective response whereas mechanical loading sufficient to induce increased work or effort was not. 12 von Leupoldt A, Sommer T, Kegat S, et al. Dyspnea and pain share emotionrelated brain network. Neuroimage 2009; 48: This study demonstrated that the perception of laboratory-induced dyspnea and pain (and their affective responses) are centrally processed in areas of the brain that constitute the limbic and paralimbic systems. 13 Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2009; 167: Santiago TV, Edelman NH. Opioids and breathing. J Appl Physiol 1985; 59: Mahler DA, Murray JA, Waterman LA, et al. Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD. Eur Respir J 2009; 33: This study demonstrated that naloxone increases dyspnea perception during exercise in patients with COPD. This effect was independent of any change in the physiological response and likely reflects central inhibition of the activity of endogenous opioids. 16 O Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol 2009; 167: Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177: Symptomatic patients with GOLD stage I COPD can have significant pathophysiologic abnormalities that lead to clinically important dyspnea and exercise intolerance. 18 Rodriguez-Roisin R, Drakulovic M, Rodriguez DA, et al. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol 2009; 106: This important study provides a comprehensive assessment of the abnormalities in pulmonary gas exchange that exist across the COPD severity range. It highlights the existence of significant gas exchange abnormalities even in patients with milder COPD. 19 O Donnell DE, Laveneziana P, Ora J, et al. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. Thorax 2009; 64: This study demonstrated that release of cholinergic tone of airway smooth muscle in mild symptomatic COPD is associated with consistent and potentially important improvements in dynamic respiratory mechanics. 20 Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009; 180: This is the first study to show a correlation between the extent of dynamic hyperinflation during cycle exercise and impairment of daily activities, in patients with COPD. 21 Ora J, Laveneziana P, Ofir D, et al. Combined effects of obesity and COPD on dyspnea and exercise tolerance. Am J Respir Crit Care Med 2009 [Epub ahead of print]. This study demonstrates that the combination of obesity and COPD does not result in an increase dyspnea perception. The negative mechanical effects of obesity are partly counterbalanced by the beneficial effects of breathing at relatively lower lung volumes. 22 Nishino T, Ide T, Sudo T, Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000; 161: Ong KC, Kor AC, Chong WF, et al. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: Jensen D, Amjadi K, Harris-McAllister V, et al. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 2008; 63: This study comfirmed that inhaled furosemide has potential dyspnea-relieving properties in COPD patients and that its effect is due in part to a bronchodilator effect. 25 Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: Eves ND, Petersen SR, Haykowsky MJ, et al. Helium-hyperoxia, exercise, and respiratory mechanics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: O Donnell DE, D Arsigny C, Webb KA. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: Palange P, Valli G, Onorati P, et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: Laude EA, Duffy NC, Baveystock C, et al. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial. Am J Respir Crit Care Med 2006; 173: Marciniuk DD, Butcher SJ, Reid JK, et al. The effects of helium-hyperoxia on 6-min walking distance in COPD: a randomized, controlled trial. Chest 2007; 131: Petrof BJ, Calderini E, Gottfried SB. Effect of CPAP on respiratory effort and dyspnea during exercise in severe COPD. J Appl Physiol 1990; 69: Eves ND, Sandmeyer LC, Wong EY, et al. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest 2009; 135: This study demonstrated that breathing a mixture of helium hyperoxia increases the intensity and duration of the exercise training in patients with COPD during pulmonary rehabilitation. 33 Collins EG, Langbein WE, Fehr L, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2008; 177: This study showed that ventilatory feedback during exercise training was effective in decreasing dynamic lung hyperinflation and exertional dyspnea intensity.
Measuring Exertional Dyspnoea in Health and Disease
Measuring Exertional Dyspnoea in Health and Disease AIMS Prof. Denis O'Donnell Respiratory Investigation Unit Kingston General Hospital & Queen s University Kingston Richardson House 102 Stuart Street
More informationFarmaci inalatori e dispnea nell asma e nella BPCO. Federico Lavorini
Farmaci inalatori e dispnea nell asma e nella BPCO Federico Lavorini Dept. Experimental and Clinical Medicine Careggi University Hospital Florence - Italy Presenter Disclosures F.L. has received in the
More informationIn patients with symptomatic COPD, desirable. Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful?
Assessment of Bronchodilator Efficacy in Symptomatic COPD* Is Spirometry Useful? Denis E. O Donnell, MD, FCCP Bronchodilator therapy in COPD is deemed successful if it improves ventilatory mechanics to
More informationQualitative aspects of breathlessness in health and disease
c Further details are published online only at http://thorax.bmj. com/content/vol64/issue8 1 Respiratory Research Group, University of Manchester, University Hospital of South Manchester, Manchester, UK;
More informationAmerican Thoracic Society Documents
American Thoracic Society Documents An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea Mark B. Parshall, Richard M. Schwartzstein, Lewis Adams,
More informationClinical exercise testing
Basic principles of clinical exercise testing Clinical exercise testing This article is adapted from the on Basic principles of clinical exercise testing organised in Rome, March 2 4, 2006. Original slides,
More informationFIGURE 1. Evolution of the use of Heliox in medicine. T. HUNT ET AL. REVIEW: HELIOX, DYSPNOEA AND EXERCISE IN COPD
Eur Respir Rev 2010; 19: 115, 30 38 DOI: 10.1183/09059180.00006009 CopyrightßERSJ Ltd 2010 REVIEW Heliox, dyspnoea and exercise in COPD T. Hunt*,#, M.T. Williams #, P. Frith* and D. Schembri* ABSTRACT:
More informationINSPIRATORY MUSCLE TRAINING IMPROVES BREATHING PATTERN DURING EXERCISE IN COPD PATIENTS
Word Count Text: 1, INSPIRATORY MUSCLE TRAINING IMPROVES BREATHING PATTERN DURING EXERCISE IN COPD PATIENTS Running Head: Exercise breathing pattern after IMT Noppawan Charususin, [PT, MSc] 1,,, Rik Gosselink,
More informationIncreased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients
Yuan et al. BMC Pulmonary Medicine 2014, 14:16 RESEARCH ARTICLE Open Access Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients Wei
More informationEndogenous opioids modify dyspnoea during treadmill exercise in patients with COPD
Eur Respir J 2009; 33: 771 777 DOI: 10.1183/09031936.00145208 CopyrightßERS Journals Ltd 2009 Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD D.A. Mahler*, J.A. Murray
More informationDyspnea: Evaluation and Management
Dyspnea: Evaluation and Management Sandra Whitlock, M.D. Four Seasons Palliative Care Course Handouts & Post Test o To download presentation handouts, click on the attachment icon o Presenter discloses
More informationPulmonary Rehabilitation in Chronic Lung Disease; Components and Organization. Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept.
Pulmonary Rehabilitation in Chronic Lung Disease; Components and Organization Prof. Dr. Müzeyyen Erk Cerrahpaşa Medical Faculty Chest Disease Dept. Plan Chronic Respiratory Disease Definition Factors Contributing
More informationTreatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1
58 COPD 59 The treatment of COPD includes drug therapy, surgery, exercise and counselling/psychological support. When managing COPD patients, it is particularly important to evaluate the social and family
More informationOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO
OOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO Subject Index ACE inhibitors, see Angiotensin-converting enzyme inhibitors Aging
More informationRegulation of respiration
Regulation of respiration Breathing is controlled by the central neuronal network to meet the metabolic demands of the body Neural regulation Chemical regulation Respiratory center Definition: A collection
More informationImpacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
Eur Respir Rev 2006; 15: 99, 37 41 DOI: 10.1183/09059180.00009903 CopyrightßERSJ Ltd 2006 Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance D.E. O Donnell ABSTRACT: The
More informationPeripheral mechanisms of dyspnoea
Peripheral mechanisms of dyspnoea Miriam Johnson 2012 A complex interaction respiratory motor areas of the brain receive information and commands required ventilation ascending copy of descending motor
More informationCurriculum Vitae. EMPLOYMENT Mar 1991 Research Associate, Respiratory Investigation Unit (Supervisor: Dr. Denis O Donnell).
Curriculum Vitae KATHERINE ALEXANDRA WEBB Kingston, Ontario, Canada work telephone: (613) 549-6666 ext.4950 work fax: (613) 548-1307 e-mail: kw2@queensu.ca EDUCATION 1988 M.Sc. (Exercise Rehabilitation);
More informationEvolution of Dyspnea during Exercise in Chronic Obstructive Pulmonary Disease Impact of Critical Volume Constraints
Evolution of Dyspnea during Exercise in Chronic Obstructive Pulmonary Disease Impact of Critical Volume Constraints Pierantonio Laveneziana 1,2, Katherine A. Webb 1, Josuel Ora 1, Karin Wadell 1, and Denis
More informationGestione della dispnea nell insufficienza respiratoria end-stage
Gestione della dispnea nell insufficienza respiratoria end-stage Salvatore M. Maggiore, MD, PhD salvatore.maggiore@unich.it Anesthesia and Intensive Care SS. Annunziata Hospital Gabriele d Annunzio University
More informationExertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing
SERIES EXERTIONAL DYSPNOEA Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing Denis E. O Donnell 1, Amany F. Elbehairy 1,2, Azmy Faisal 1,3, Katherine A. Webb 1, J. Alberto
More informationCOPD is a progressive disorder leading to increasing
Improvement in Exercise Tolerance With the Combination of Tiotropium and Pulmonary Rehabilitation in Patients With COPD* Richard Casaburi, MD, PhD, FCCP; David Kukafka, MD, FCCP; Christopher B. Cooper,
More informationControl of Respiration
Control of Respiration Graphics are used with permission of: adam.com (http://www.adam.com/) Benjamin Cummings Publishing Co (http://www.awl.com/bc) Page 1. Introduction The basic rhythm of breathing is
More informationEXERCISE LIMITATION IN MILD COPD: THE ROLE OF RESPIRATORY MECHANICAL FACTORS
EXERCISE LIMITATION IN MILD COPD: THE ROLE OF RESPIRATORY MECHANICAL FACTORS By Roberto Carlos Chin A thesis submitted to the Physiology Graduate Program in the Department of Biomedical and Molecular Sciences
More informationThe effect of opioid use on pulmonary function test in advanced COPD patients
The effect of opioid use on pulmonary function test in advanced COPD patients Parinaz Koohi Habibi Dehkordi (1) Sayed Mahdi Ayat (1) Hamid Rouhi Boroujeni (2) Hamid Sohrabpour (3) Abbas Fadaei (4) (1)
More informationInspiratory Resistance Decreases Limb Blood Flow in COPD Patients with Heart Failure
ERJ Express. Published on November 14, 2013 as doi: 10.1183/09031936.00166013 Letter to the Editor Inspiratory Resistance Decreases Limb Blood Flow in COPD Patients with Heart Failure Gaspar R. Chiappa
More informationStrategies of muscle training in very severe COPD patients
Eur Respir J 2011; 38: 971 975 DOI: 10.1183/09031936.00075011 CopyrightßERS 2011 SERIES: NOVELTIES IN PULMONARY REHABILITATION Edited by E. Clini and N. Ambrosino Number 2 in this Series Strategies of
More informationSam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation
Sam H Ahmedzai Academic Unit of Supportive Care Department of Oncology The University of Sheffield & Sheffield Teaching Hospitals NHS Foundation Trust Overview Which drugs? How much? How to give? Adverse
More informationEffects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary Disease
Effects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary Disease DENIS E. O DONNELL, CHRISTINE D ARSIGNY, and KATHERINE A. WEBB Respiratory Investigation
More informationDECLINE OF RESTING INSPIRATORY CAPACITY IN COPD: THE IMPACT ON BREATHING PATTERN, DYSPNEA AND VENTILATORY CAPACITY DURING EXERCISE
Page 1 of 29 Body of text word count: 2,836 Abstract word count: 250 DECLINE OF RESTING INSPIRATORY CAPACITY IN COPD: THE IMPACT ON BREATHING PATTERN, DYSPNEA AND VENTILATORY CAPACITY DURING EXERCISE Authors:
More informationDistractive Auditory Stimuli Alleviate the Perception of Dyspnea Induced by Low-Intensity Exercise in Elderly Subjects With COPD
Distractive Auditory Stimuli Alleviate the Perception of Dyspnea Induced by Low-Intensity Exercise in Elderly Subjects With COPD Kazuya Shingai PT MSc, Masashi Kanezaki PT PhD, and Hideaki Senjyu PT PhD
More information3 COPD Recognition and Diagnosis: Approach to the Patient with Respiratory Symptoms
William L. Eschenbacher, MD 3 COPD Recognition and Diagnosis: Approach to the Patient with Respiratory Symptoms Key Points 1. Patients who present with respiratory symptoms such as cough, sputum production,
More informationDescriptors of Breathlessness in Patients With Cancer and Other Cardiorespiratory Diseases
182 Journal of Pain and Symptom Management Vol. 23 No. 3 March 2002 Original Article Descriptors of Breathlessness in Patients With Cancer and Other Cardiorespiratory Diseases Andrew Wilcock, DM, FRCP,
More informationDyspnea. Stephanie Lindsay
Dyspnea Stephanie Lindsay What is dyspnea? An unpleasant sensation of difficult, labored breathing Shortness of air Dyspnea is not the same as tachypnea therefore patients may not present with rapid breathing
More informationMultidimensional Dyspnea Profile: an instrument for clinical and laboratory research
ERJ Express. Published on March 18, 2015 as doi: 10.1183/09031936.00038914 Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research Robert B. Banzett 1,2, Carl R. O Donnell
More informationEffects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
ORIGINAL ARTICLE COPD Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD Denis E. O Donnell 1, Richard Casaburi 2, Peter Frith 3, Anne Kirsten 4, Dorothy De
More informationLung-Brain interactions in critically ill patients receiving Mechanical Ventilation
Lung-Brain interactions in critically ill patients receiving Mechanical Ventilation Lluís Blanch MD, PhD Senior Critical Care Director of Research and Innovation Corporació Sanitària Parc Taulí WFSICCM
More informationB reathlessness is the most disabling symptom associated
8 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease N J Stevenson, P M A Calverley... See end of article for
More informationTeacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology
Title: Spirometry Teacher : Dorota Marczuk Krynicka, MD., PhD. Coll. Anatomicum, Święcicki Street no. 6, Dept. of Physiology I. Measurements of Ventilation Spirometry A. Pulmonary Volumes 1. The tidal
More informationRespiratory Physiology Part II. Bio 219 Napa Valley College Dr. Adam Ross
Respiratory Physiology Part II Bio 219 Napa Valley College Dr. Adam Ross Gas exchange Gas exchange in the lungs (to capillaries) occurs by diffusion across respiratory membrane due to differences in partial
More informationPulmonary rehabilitation in severe COPD.
Pulmonary rehabilitation in severe COPD daniel.langer@faber.kuleuven.be Content Rehabilitation (how) does it work? How to train the ventilatory limited patient? Chronic Obstructive Pulmonary Disease NHLBI/WHO
More informationBi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients Objectives Describe nocturnal ventilation characteristics that may indicate underlying conditions and benefits of bilevel therapy for specific
More informationEvaluation of Effect of Breathe Ventilation System on Work of Breathing in COPD patients. Matthew Cohn, M.D.
Evaluation of Effect of Breathe Ventilation System on Work of Breathing in COPD patients Matthew Cohn, M.D. 1 11/4/2013 Disclosure Slide- Matthew Cohn, M.D. Personal financial relationships with commercial
More informationCourse Handouts & Disclosure
COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation
More informationReview Article Inspiratory Capacity during Exercise: Measurement, Analysis, and Interpretation
Hindawi Publishing Corporation Pulmonary Medicine Volume 2013, Article ID 956081, 13 pages http://dx.doi.org/10.1155/2013/956081 Review Article Inspiratory Capacity during Exercise: Measurement, Analysis,
More informationObjectives. Objectives. Definition. Physiology. Evaluation of the Dyspneic Patient. B. Celli Disclaimer
Evaluation of the Dyspneic Patient Bartolome R. Celli Harvard Medical School Brigham and Women s Hospital Boston B. Celli Disclaimer No stocks or ownership in any company. No Tobacco funds No promotional
More informationYU DTW, Chan ACM, Poon MWY, Lau PMY. Physiotherapy Departments Kowloon Central Cluster
YU DTW, Chan ACM, Poon MWY, Lau PMY Physiotherapy Departments Kowloon Central Cluster Prevalence of Ca Lung and COPD Hong Kong Cancer Registry Hospital Authority Annual Report 2012-13 Breathlessness /
More informationPulmonary Function Testing: Concepts and Clinical Applications. Potential Conflict Of Interest. Objectives. Rationale: Why Test?
Pulmonary Function Testing: Concepts and Clinical Applications David M Systrom, MD Potential Conflict Of Interest Nothing to disclose pertinent to this presentation BRIGHAM AND WOMEN S HOSPITAL Harvard
More information6- Lung Volumes and Pulmonary Function Tests
6- Lung Volumes and Pulmonary Function Tests s (PFTs) are noninvasive diagnostic tests that provide measurable feedback about the function of the lungs. By assessing lung volumes, capacities, rates of
More informationA physiological model of patient-reported breathlessness during daily activities in COPD
Eur Respir Rev 2009; 18: 112, 66 79 DOI: 10.1183/09059180.00000809 CopyrightßERSJ Ltd 2009 REVIEW A physiological model of patient-reported breathlessness during daily activities in COPD C.J. Jolley and
More informationSpirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease
Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease DENIS E. O DONNELL, MIU LAM, and KATHERINE A. WEBB Respiratory Investigation
More informationKey words: computer administration; continuous method for rating breathlessness; exercise testing
Comparison of Continuous and Discrete Measurements of Dyspnea During Exercise in Patients With COPD and Normal Subjects* Gustavo Fierro-Carrion, MD; Donald A. Mahler, MD, FCCP; Joseph Ward, RCPT; and John
More informationObjectives. Ethical Issues at EOL: Deciding When to Use Oxygen and Antibiotics. Dyspnea. To Palliate 4/28/2014
Objectives Ethical Issues at EOL: Deciding When to Use Oxygen and Antibiotics Marcia Levetown, MD, FAAHPM HealthCare Communication Associates mlevetown@earthlink.net Understand the evidence based use of
More informationCh 16 A and P Lecture Notes.notebook May 03, 2017
Table of Contents # Date Title Page # 1. 01/30/17 Ch 8: Muscular System 1 2. 3. 4. 5. 6. 7. 02/14/17 Ch 9: Nervous System 12 03/13/17 Ch 10: Somatic and Special Senses 53 03/27/17 Ch 11: Endocrine System
More informationChapters 9 & 10. Cardiorespiratory System. Cardiovascular Adjustments to Exercise. Cardiovascular Adjustments to Exercise. Nervous System Components
Cardiorespiratory System Chapters 9 & 10 Cardiorespiratory Control Pulmonary ventilation Gas exchange Left heart Arterial system Tissues Right heart Lungs Pulmonary ventilation Cardiovascular Regulation-
More informationQuantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12
c Additional figures and tables are published online only at http://thorax.bmj.com/content/ vol65/issue1 1 School of Nursing, Faculty of Health and Social Care, University of Salford, Greater Manchester,
More informationPulmonary Pathophysiology
Pulmonary Pathophysiology 1 Reduction of Pulmonary Function 1. Inadequate blood flow to the lungs hypoperfusion 2. Inadequate air flow to the alveoli - hypoventilation 2 Signs and Symptoms of Pulmonary
More informationThe addition of non-invasive ventilation during exercise training in COPD patients. Enrico Clini and Michelle Chatwin
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.
More informationDyspnea and leg effort during exercise
Respiratory Medicine (2005) 99, 933 942 REVIEW Dyspnea and leg effort during exercise Loredana Stendardi a,b, Michela Grazzini a,b, Francesco Gigliotti a, Pamela Lotti a,b, Giorgio Scano a,b, a Fondazione
More informationDoes the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
AUTHOR COPY ORIGINAL RESEARCH Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Kian-Chung Ong 1 Suat-Jin Lu 1 Cindy Seok-Chin Soh 2 1 Department
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationPDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 31 Oct 2018 11:13:48 GMT) CTRI Number Last Modified On 17/01/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
More informationEvaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD
c Additional Methods data are published online only at http:// thorax.bmj.com/content/vol64/ issue3 1 Respiratory Investigation Unit, Department of Medicine, Queen s University and Kingston General Hospital,
More informationVentilatory limitation and the associated respiratory
Ventilatory limitations in chronic obstructive pulmonary disease DENIS E. O DONNELL Departments of Medicine and Physiology, Division of Respiratory and Critical Care Medicine, Queen s University, Kingston,
More informationDevelopment of a self-reported Chronic Respiratory Questionnaire (CRQ-SR)
954 Department of Respiratory Medicine, University Hospitals of Leicester, Glenfield Hospital, Leicester LE3 9QP, UK J E A Williams S J Singh L Sewell M D L Morgan Department of Clinical Epidemiology and
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: lung_volume_reduction_surgery 4/1996 3/2018 3/2019 3/2018 Description of Procedure or Service Emphysema is
More informationDr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE
Dr. A. Kerigan BREATHLESSNESS AT THE END OF LIFE Faculty/Presenter Disclosure Faculty: Dr. A. Kerigan Relationships with commercial interests:* - Grants/Research Support: None - Speakers Bureau/Honoraria:
More informationChapter 3. Pulmonary Function Study Assessments. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 3 Pulmonary Function Study Assessments 1 Introduction Pulmonary function studies are used to: Evaluate pulmonary causes of dyspnea Differentiate between obstructive and restrictive pulmonary disorders
More informationThe Importance of Pulmonary Rehabilitation
November 21, 2017 The Importance of Pulmonary Rehabilitation Presenter: George Pyrgos, MD 1 The importance of Pulmonary Rehabilitation George Pyrgos, MD Medical Director of the Angelos Lung Center at Medstar
More informationPreoperative assessment for lung resection. RA Dyer
Preoperative assessment for lung resection RA Dyer 2016 The ideal assessment of operative risk would identify every patient who could safely tolerate surgery. This ideal is probably unattainable... Mittman,
More informationDyspnoea: a multidimensional and multidisciplinary approach
REVIEW DYSPNOEA Dyspnoea: a multidimensional and multidisciplinary approach Louis Laviolette 1,2,3,7 and Pierantonio Laveneziana 1,2,4,5,7, on behalf of the ERS Research Seminar Faculty 6 Affiliations:
More informationBusiness. Midterm #1 is Monday, study hard!
Business Optional midterm review Tuesday 5-6pm Bring your Physio EX CD to lab this week Homework #6 and 7 due in lab this week Additional respiratory questions need to be completed for HW #7 Midterm #1
More informationSymptom Management and Palliative Care for Lung Cancer
Symptom Management and Palliative Care for Lung Cancer DorAnne Donesky, PhD, ANP-BC, ACHPN Professor of Clinical Nursing Dept of Physiological Nursing Disclosures The presenter has no relevant financial
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationChronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe
More informationPULMONARY FUNCTION TESTING. Purposes of Pulmonary Tests. General Categories of Lung Diseases. Types of PF Tests
PULMONARY FUNCTION TESTING Wyka Chapter 13 Various AARC Clinical Practice Guidelines Purposes of Pulmonary Tests Is lung disease present? If so, is it reversible? If so, what type of lung disease is present?
More informationKey points REVIEW. 100 Breathe December 2004 Volume 1 No 2
Key points Dyspnoea is the sensation of breathing discomfort that can be described with different terms according to different pathophysiological mechanisms that vary in intensity. The mechanisms of dyspnoea
More information216 Volume 26, Number 3
Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma Authors: Karla R. Kendrick, RN, MSN, Sunita C. Baxi, MD, and Robert M. Smith, MD, San Diego,
More information(FEVI) and vital capacity (VC) were recorded
99 Department of Thoracic Medicine S E J Keilty T A Fleming J Moxham Department of Anaesthesia J Ponte King's Coliege School of Medicine and Dentistry, Bessemer Road, London SES 9PJ, UK Reprint requests
More informationKey words: exercise therapy; exercise tolerance; lung diseases; obstructive; oxygen consumption; walking
Exercise Outcomes After Pulmonary Rehabilitation Depend on the Initial Mechanism of Exercise Limitation Among Non-Oxygen-Dependent COPD Patients* John F. Plankeel, MD; Barbara McMullen, RRT; and Neil R.
More informationBasic approach to PFT interpretation. Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic
Basic approach to PFT interpretation Dr. Giulio Dominelli BSc, MD, FRCPC Kelowna Respiratory and Allergy Clinic Disclosures Received honorarium from Astra Zeneca for education presentations Tasked Asked
More informationBenefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
ORIGINAL RESEARCH Benefi ts of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients Barakat Shahin 1 Michele Germain 2 Alzahouri Kazem 3 Guy Annat
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationPulmonary Function Testing
In the Clinic Pulmonary Function Testing Hawa Edriss MD, Gilbert Berdine MD The term PFT encompasses three different measures of lung function: spirometry, lung volumes, and diffusion capacity. In this
More informationTEAM Educational Module Page 1 of 11
TEAM Educational Module Page 1 of 11 Control of Breathing during Wakefulness and Sleep Learning Objectives:? Describe the elements of ventilatory control (e.g. central control of rate and depth, chemo-
More informationDyspnea and Activity Limitation in COPD: Mechanical Factors
COPD: Journal of Chronic Obstructive Pulmonary Disease ISSN: 1541-2555 (Print) 1541-2563 (Online) Journal homepage: http://www.tandfonline.com/loi/icop20 Dyspnea and Activity Limitation in COPD: Mechanical
More informationDear Reader, What was the study about? Why was the research needed? BI NCT
Dear Reader, Sponsors of clinical studies create study reports. A study report describes how the study was done and what the results of the study were. This is a summary of such a report. It is meant for
More informationIs there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life?
Is there any evidence that multi disciplinary pulmonary rehabilitation impacts on quality of life? Summary of the evidence located: According to the NICE guideline on Chronic Obstructive Pulmonary Disease
More informationI Can t Breathe! Physiology and Evaluation of the Dyspneic Patient. Christopher Parker, MD Pulmonology, Norman Regional Health Systems
I Can t Breathe! Physiology and Evaluation of the Dyspneic Patient Christopher Parker, MD Pulmonology, Norman Regional Health Systems Photo by James Heilman, MD / CC BY-SA 3.0 Disclosures No Financial
More informationExercise Stress Testing: Cardiovascular or Respiratory Limitation?
Exercise Stress Testing: Cardiovascular or Respiratory Limitation? Marshall B. Dunning III, Ph.D., M.S. Professor of Medicine & Physiology Medical College of Wisconsin What is exercise? Physical activity
More informationEffect of N-Acetylcysteine on Air Trapping in COPD. A Randomized Placebo-Controlled Study
CHEST Effect of N-Acetylcysteine on Air Trapping in COPD A Randomized Placebo-Controlled Study David Stav, MD; and Meir Raz, MD Original Research COPD Background: FEV 1 is used for the classification of
More informationMonitoring Respiratory Drive and Respiratory Muscle Unloading during Mechanical Ventilation
Monitoring Respiratory Drive and Respiratory Muscle Unloading during Mechanical Ventilation J. Beck and C. Sinderby z Introduction Since Galen's description 2000 years ago that the lungs could be inflated
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Pre morbid Severity of Chronic Obstructive Pulmonary Disease as Risk Factor for Carbon dioxide Retention during Acute Exacerbation of
More informationExercise limitation and the breathlessness. Exercise and dyspnoea in COPD. P.M.A. Calverley
Eur Respir Rev 2006; 15: 100, 72 79 DOI: 10.1183/09059180.00010004 CopyrightßERSJ Ltd 2006 Exercise and dyspnoea in COPD P.M.A. Calverley ABSTRACT: Dyspnoea provoked either by exercise or during a disease
More informationLecture Notes. Chapter 3: Asthma
Lecture Notes Chapter 3: Asthma Objectives Define asthma and status asthmaticus List the potential causes of asthma attacks Describe the effect of asthma attacks on lung function List the clinical features
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationCOMPARISON BETWEEN INTERCOSTAL STRETCH AND BREATHING CONTROL ON PULMONARY FUNCTION PARAMETER IN SMOKING ADULTHOOD: A PILOT STUDY
COMPARISON BETWEEN INTERCOSTAL STRETCH AND BREATHING CONTROL ON PULMONARY FUNCTION PARAMETER IN SMOKING ADULTHOOD: A PILOT STUDY Shereen Inkaew 1 Kamonchat Nalam 1 Panyaporn Panya 1 Pramook Pongsuwan 1
More information